Literature DB >> 21872901

Protein kinase biochemistry and drug discovery.

Phillip A Schwartz1, Brion W Murray.   

Abstract

Protein kinases are fascinating biological catalysts with a rapidly expanding knowledge base, a growing appreciation in cell regulatory control, and an ascendant role in successful therapeutic intervention. To better understand protein kinases, the molecular underpinnings of phosphoryl group transfer, protein phosphorylation, and inhibitor interactions are examined. This analysis begins with a survey of phosphate group and phosphoprotein properties which provide context to the evolutionary selection of phosphorylation as a central mechanism for biological regulation of most cellular processes. Next, the kinetic and catalytic mechanisms of protein kinases are examined with respect to model aqueous systems to define the elements of catalysis. A brief structural biology overview further delves into the molecular basis of catalysis and regulation of catalytic activity. Concomitant with a prominent role in normal physiology, protein kinases have important roles in the disease state. To facilitate effective kinase drug discovery, classic and emerging approaches for characterizing kinase inhibitors are evaluated including biochemical assay design, inhibitor mechanism of action analysis, and proper kinetic treatment of irreversible inhibitors. As the resulting protein kinase inhibitors can modulate intended and unintended targets, profiling methods are discussed which can illuminate a more complete range of an inhibitor's biological activities to enable more meaningful cellular studies and more effective clinical studies. Taken as a whole, a wealth of protein kinase biochemistry knowledge is available, yet it is clear that a substantial extent of our understanding in this field remains to be discovered which should yield many new opportunities for therapeutic intervention.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21872901     DOI: 10.1016/j.bioorg.2011.07.004

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  27 in total

1.  Site-specific NMR mapping and time-resolved monitoring of serine and threonine phosphorylation in reconstituted kinase reactions and mammalian cell extracts.

Authors:  Francois-Xavier Theillet; Honor May Rose; Stamatios Liokatis; Andres Binolfi; Rossukon Thongwichian; Marchel Stuiver; Philipp Selenko
Journal:  Nat Protoc       Date:  2013-06-27       Impact factor: 13.491

Review 2.  The ancient microbial RIO kinases.

Authors:  Nicole A LaRonde
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

3.  A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases.

Authors:  Hidehisa Iwata; Hideyuki Oki; Kengo Okada; Terufumi Takagi; Michiko Tawada; Yasushi Miyazaki; Shinichi Imamura; Akira Hori; J David Lawson; Mark S Hixon; Hiroyuki Kimura; Hiroshi Miki
Journal:  ACS Med Chem Lett       Date:  2012-02-28       Impact factor: 4.345

4.  FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures.

Authors:  Tobias Klein; Julie Tucker; Geoffrey A Holdgate; Richard A Norman; Alexander L Breeze
Journal:  ACS Med Chem Lett       Date:  2013-12-06       Impact factor: 4.345

5.  5'-β,γ-CHF-ATP diastereomers: synthesis and fluorine-mediated selective binding by c-Src protein kinase.

Authors:  Candy S Hwang; Alvin Kung; Boris A Kashemirov; Chao Zhang; Charles E McKenna
Journal:  Org Lett       Date:  2015-03-17       Impact factor: 6.005

6.  Kinetic and structural analyses reveal residues in phosphoinositide 3-kinase α that are critical for catalysis and substrate recognition.

Authors:  Sweta Maheshwari; Michelle S Miller; Robert O'Meally; Robert N Cole; L Mario Amzel; Sandra B Gabelli
Journal:  J Biol Chem       Date:  2017-07-04       Impact factor: 5.157

7.  Time-gated luminescence microscopy with responsive nonmetal probes for mapping activity of protein kinases in living cells.

Authors:  Angela Vaasa; Kadri Ligi; Shabnam Mohandessi; Erki Enkvist; Asko Uri; Lawrence W Miller
Journal:  Chem Commun (Camb)       Date:  2012-07-20       Impact factor: 6.222

8.  Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance.

Authors:  Phillip A Schwartz; Petr Kuzmic; James Solowiej; Simon Bergqvist; Ben Bolanos; Chau Almaden; Asako Nagata; Kevin Ryan; Junli Feng; Deepak Dalvie; John C Kath; Meirong Xu; Revati Wani; Brion William Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-17       Impact factor: 11.205

9.  The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic Cleft.

Authors:  Peter Silhár; Matthew A Lardy; Mark S Hixon; Charles B Shoemaker; Joseph T Barbieri; Anjali K Struss; Jenny M Lively; Sacha Javor; Kim D Janda
Journal:  ACS Med Chem Lett       Date:  2012-12-23       Impact factor: 4.345

10.  Novel VEGFR-2 kinase inhibitors identified by the back-to-front approach.

Authors:  Kingkan Sanphanya; Suvara K Wattanapitayakul; Suwadee Phowichit; Valery V Fokin; Opa Vajragupta
Journal:  Bioorg Med Chem Lett       Date:  2013-03-20       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.